在帕金森病中,患者对上肢日常功能的看法
Noa Cohen1,2,3, Rachel Kizony1
1Occupational Therapy Department, Faculty of Social Welfare & Health Sciences, University of Haifa, Haifa, Israel.
Movement disorders clinical practice
|November 20, 2024
概括
患有帕金森病的人因敏捷性问题而难以完成日常任务,例如使用触摸屏和穿衣. 了解这些挑战对于有效的上肢干预至关重要.
科学领域:
- 神经学 神经学
- 康复科学 康复科学 康复科学
- 职业疗法 职业疗法 职业疗法
背景情况:
- 敏捷性障碍显著影响患有帕金森病 (PWP) 的患者.
- 上肢 (UL) 功能障碍对PWP患者日常活动的影响尚不清楚.
- 识别特定的灵巧挑战是提高PWP功能独立性的关键.
研究的目的:
- 确定对PWP影响和意义最大的灵巧活动.
- 探索感知灵巧度与疾病严重程度,认知/运动障碍,灵巧能力,ADL功能和生活质量 (QOL) 之间的相关性.
- 确定影响感知灵敏度的因素,并根据受影响的主导地位检查差异.
主要方法:
- 43名PWP (平均年龄70岁) 用敏捷性问卷 (DextQ-36),硬币旋转任务,霍恩和雅尔量表,MDS-UPDRS,MoCA和PDQ-39进行评估.
- 评估感知敏捷性,敏捷性能力,疾病严重程度,UL运动障碍,认知和QOL.
- 数据分析探讨了感知灵巧度的关联和解释变量.
主要成果:
- 困难而有意义的灵巧任务包括使用触摸屏,打扮和拨打电话.
- 感知灵巧度与ADL功能 (r=0.716),QOL (r=0.691),疾病严重程度 (r=0.470) 和主导手的灵巧度 (r=0.432) 强烈相关.
- 灵巧能力和疾病严重程度解释了30%的感知灵巧差异;没有根据主导影响发现差异.
结论:
- 在复杂的灵巧任务中,PWP面临重大挑战,影响其独立性.
- 对PWP的临床评估应纳入有关敏捷性相关活动的意义的问题.
- 针对UL功能的有针对性的干预措施需要对个体的灵巧性限制有充分的了解.
更多相关视频
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
496
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
1.1K
相关概念视频
01:24Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
01:15Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482